PatientsVille.com Logo

PatientsVille

Magnex Side Effects

Common Magnex Side Effects


The most commonly reported Magnex side effects (click to view or check a box to report):

Platelet Count Decreased (8)
Thrombocytopenia (7)
Prothrombin Time Prolonged (5)
Anaphylactic Shock (4)
International Normalised Ratio Increased (4)
Renal Failure Acute (3)
Gastrointestinal Haemorrhage (3)
Sepsis (3)
Septic Shock (3)
Rash (3)
Haemorrhage Urinary Tract (3)
Grand Mal Convulsion (3)
Death (3)
Post Procedural Haemorrhage (2)
Respiratory Arrest (2)
Haematuria (2)
Abdominal Abscess (2)
Tracheal Haemorrhage (2)
Cardiac Arrest (2)
Cerebral Haemorrhage (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Magnex Side Effects Reported to FDA

The following Magnex reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Magnex on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anaphylactic Shock
This is a report of a 34-year-old female patient (weight: NA) from INDIA, suffering from the following symptoms/conditions: infection, who was treated with Magnex (dosage: 1 G, Unk, start time: Oct 14, 2010), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Anaphylactic Shock
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnex treatment in female patients, resulting in anaphylactic shock side effect.

Anaphylactic Shock
This report suggests a potential Magnex Anaphylactic Shock side effect(s) that can have serious consequences. A 34-year-old female patient (weight: NA) from INDIA was diagnosed with the following symptoms/conditions: infection and used Magnex (dosage: Unk) starting NS. Soon after starting Magnex the patient began experiencing various side effects, including:
  • Anaphylactic Shock
Drugs used concurrently: NA. Although Magnex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as anaphylactic shock, may still occur.


This problem was reported by a physician from INDIA. A 52-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: sepsis. On NS this consumer started treatment with Magnex (dosage: 1.5 G, 3x/day). The following drugs were being taken at the same time:
  • Amikacin (1 G, 1x/day)
When commencing Magnex, the patient experienced the following unwanted symptoms/side effects:
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as death, may become evident only after a product is in use by the general population.


    This is a report of a 85-year-old male patient (weight: NA) from INDIA. The patient developed the following symptoms/conditions: pneumonia and was treated with Magnex (dosage: 3 G, 2x/day) starting NS. Concurrently used drugs:
    • Metrogyl (500 Mg, 3x/day)
    Soon after that, the consumer experienced the following side effects:
      This opens a possibility that Magnex treatment could cause the above reactions, including death, and some male subjects may be more susceptible.


      Stevens-johnson Syndrome
      A 57-year-old male patient (weight: NA) from INDIA with the following symptoms/conditions: NA started Magnex treatment (dosage: 3 G, 1x/day) on Aug 30, 2010. Soon after starting Magnex treatment, the subject experienced various side effects, including:
      • Stevens-johnson Syndrome
      Concurrently used drugs:
      • Amlodipine (Unk)
      • Atenolol (Unk)
      • Minipress Xl (Unk)
      • Shelcal (Unk)
      • Atorvastatin (Unk)
      • Iron (Unk)
      • Folate (Unk)
      • Pantoprazole (Unk)
      The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Magnex.

      Blood Glucose Increased, Pneumonia, Stevens-johnson Syndrome
      A 67-year-old male patient from INDIA (weight: NA) experienced symptoms, such as: NA and was treated with Magnex(dosage: 3 G, 1x/day). The treatment was initiated on Aug 28, 2010. After that a consumer reported the following side effect(s):
      • Blood Glucose Increased
      • Pneumonia
      • Stevens-johnson Syndrome
      Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Magnex efficacy:
      • Atorvastatin
      • Mixtard Human 70/30 (40 Iu)
      • Ranitidine
      • Amlodipine
      • Clopidogrel
      • Erythropoietin


      Acute Respiratory Distress Syndrome, Atrial Fibrillation, Chest Discomfort, Decubitus Ulcer, Dyspnoea, Hyperhidrosis, Lower Respiratory Tract Infection, Pleural Effusion, Sepsis
      In this report, Magnex was administered for the following condition: NA.A 69-year-old male consumer from INDIA (weight: NA) started Magnex treatment (dosage: 1 G, 2x/day) on Oct 20, 2008.Sometime after starting the treatment, the patient complained of the following side effect(s):
      • Acute Respiratory Distress Syndrome
      • Atrial Fibrillation
      • Chest Discomfort
      • Decubitus Ulcer
      • Dyspnoea
      • Hyperhidrosis
      • Lower Respiratory Tract Infection
      • Pleural Effusion
      • Sepsis
      A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Magnex treatment could be related to the listed above side effect(s).

      Full Blood Count Decreased
      This is a report of the following Magnex side effect(s):
      • Full Blood Count Decreased
      A 52-year-old female patient from INDIA (weight: NA) presented with the following condition: sepsis and received a treatment with Magnex (dosage: Unk) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Magnex treatment could be associated with the listed above side effect(s).

      Thrombocytopenia
      This Magnex report was submitted by a 45-year-old male consumer from INDIA (weight: NA). The patient was diagnosed with: surgery and Magnex was administered (dosage: 1 G, 2x/day) starting: NS. The consumer developed a set of symptoms:
      • Thrombocytopenia
      Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Magnex treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

      Pancytopenia
      This is a report of a possible correlation between Magnex use and the following symptoms/side effect(s):
      • Pancytopenia
      which could contribute to an assessment of Magnex risk profile.A 42-year-old male consumer from INDIA (weight: NA) was suffering from head injury,epilepsy and was treated with Magnex (dosage: 2 G, 3x/day) starting Jan 04, 2010.Other concurrent medications:
      • Phenytoin (Unk)


      Rash
      A 12-year-old patient from INDIA (weight: NA) presented with the following symptoms: wound infection and after a treatment with Magnex (dosage: 1.5 G, 2x/day) experienced the following side effect(s):
      • Rash
      The treatment was started on Jun 03, 2009. Magnex was used in combination with the following drugs:
      • Vancomycin
      This report could alert potential Magnex consumers.

      Cerebral Haemorrhage, Gastrointestinal Haemorrhage, Haematuria, Thrombocytopenia
      In this report, a 28-year-old patient from INDIA (weight: NA) was affected by a possible Magnex side effect.The patient was diagnosed with sepsis,multiple injuries. After a treatment with Magnex (dosage: 2 G, 2x/day, start date: Aug 23, 2009), the patient experienced the following side effect(s):
      • Cerebral Haemorrhage
      • Gastrointestinal Haemorrhage
      • Haematuria
      • Thrombocytopenia
      The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Magnex treatment.

      Thrombocytopenia
      This is a report of a 28-year-old patient from INDIA (weight: NA), who used Magnex (dosage: 2 G, 2x/day) for a treatment of head injury. After starting a treatment on Aug 23, 2009, the patient experienced the following side effect(s):
      • Thrombocytopenia
      The following drugs could possibly have interacted with the Magnex treatment
      • Gentamicin
      Taken together, these observations suggest that a Magnex treatment could be related to side effect(s), such as Thrombocytopenia.

      Rash
      This rash side effect was reported by a physician from INDIA. A 12-year-old patient (weight:NA) experienced the following symptoms/conditions: wound infection. The patient was prescribed Magnex (dosage: 1.5 G, 2x/day), which was started on Jun 03, 2009. Concurrently used drugs:
      • Vancomycin
      When starting to take Magnex the consumer reported the following symptoms:
      • Rash
      These side effects may potentially be related to Magnex.

      Rash
      This is a Magnex side effect report of a 12-year-old patient (weight:NA) from INDIA, suffering from the following symptoms/conditions: wound infection, who was treated with Magnex (dosage:1.5 G, 2x/day, start time: Jun 03, 2009), combined with:
      • Vancomycin
      , and developed a serious reaction and a rash side effect. The patient presented with:
      • Rash
      which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Magnex treatment in patients suffering from wound infection, resulting in rash.

      Blood Pressure Decreased, Pyrexia
      This report suggests a potential Magnex blood pressure decreased side effect(s) that can have serious consequences. A 28-year-old male patient from INDIA (weight:NA) was diagnosed with the following health condition(s): acute respiratory distress syndrome and used Magnex (dosage: NA) starting Sep 23, 2008. Soon after starting Magnex the patient began experiencing various side effects, including:
      • Blood Pressure Decreased
      • Pyrexia
      Drugs used concurrently:NA. The patient was hospitalized. Although Magnex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as blood pressure decreased, may still occur.

      Platelet Count Decreased, Septic Shock
      This platelet count decreased problem was reported by a physician from INDIA. A 23-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): peritonitis.On May 14, 2008 a consumer started treatment with Magnex (dosage: NA). The following drugs/medications were being taken at the same time:
      • Metronidazole
      • Amikacin
      • Vitamin K Tab
      When commencing Magnex, the patient experienced the following unwanted symptoms /side effects:
      • Platelet Count Decreased
      • Septic Shock
      Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as platelet count decreased, may become evident only after a product is in use by the general population.

      Platelet Count Decreased
      This is a Magnex side effect report of a 23-year-old male patient (weight: NA) from INDIA. The patient developed the following symptoms/conditions: peritonitis and was treated with Magnex (dosage: NA) starting May 14, 2008. Concurrently used drugs:
      • Metronidazole Hcl
      • Amikacin
      • Vitamin K Tab
      Soon after that, the consumer experienced the following of symptoms:
      • Platelet Count Decreased
      This opens a possibility that Magnex could cause platelet count decreased and that some male patients may be more susceptible.

      International Normalised Ratio Increased
      A 50-year-old male patient (weight: NA) from INDIA with the following symptoms: lung infection started Magnex treatment (dosage: NA) on NS. Soon after starting Magnex treatment, the consumer experienced several side effects, including:
      • International Normalised Ratio Increased
      . Concurrently used drugs:
      • Amikacin
      The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Magnex side effects, such as international normalised ratio increased.

      International Normalised Ratio Increased
      This international normalised ratio increased side effect was reported by a physician from INDIA. A 50-year-old male patient (weight:NA) experienced the following symptoms/conditions: lung infection.The patient was prescribed Magnex (dosage: NA), which was started on NS. Concurrently used drugs:
      • Amikacin
      .When starting to take Magnex the consumer reported symptoms, such as:
      • International Normalised Ratio Increased
      These side effects may potentially be related to Magnex. The patient was hospitalized.

      Septic Shock
      This is a report of a 30-year-old male patient (weight: NA) from INDIA, suffering from the following symptoms/conditions: sepsis, who was treated with Magnex (dosage: NA, start time: Oct 31, 2007), combined with:
      • Meronem
      and developed a serious reaction and side effect(s). The consumer presented with:
      • Septic Shock
      which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Magnex treatment in male patients, resulting in death side effect.

      Septic Shock
      This report suggests a potential Magnex Septic Shock side effect(s) that can have serious consequences. A 30-year-old male patient (weight: NA) from INDIA was diagnosed with the following symptoms/conditions: sepsis and used Magnex (dosage: NA) starting Oct 31, 2007. Soon after starting Magnex the patient began experiencing various side effects, including:
      • Septic Shock
      Drugs used concurrently:
      • Meronem
      Although Magnex demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as septic shock, may still occur.

      Graft Haemorrhage, Haematuria
      This Graft Haemorrhage, Haematuria problem was reported by a physician from INDIA. A 80-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hydropneumothorax. On NS this consumer started treatment with Magnex (dosage: NA). The following drugs were being taken at the same time:
      • Enoxaparin Sodium (Daily Dose:.4ml)
      • Acetylsalicylic Acid/clopidogrel (Daily Dose:150mg)
      • I.v. Solutions
      When commencing Magnex, the patient experienced the following unwanted symptoms/side effects:
      • Graft Haemorrhage
      • Haematuria
      Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as graft haemorrhage, may become evident only after a product is in use by the general population.

      Disseminated Intravascular Coagulation, Haemorrhage Urinary Tract
      This is a report of a 60-year-old male patient (weight: NA) from INDIA. The patient developed the following symptoms/conditions: respiratory tract infection and was treated with Magnex (dosage: NA) starting NS. Concurrently used drugs:
      • Amikacin
      Soon after that, the consumer experienced the following side effects:
      • Disseminated Intravascular Coagulation
      • Haemorrhage Urinary Tract
      The patient was hospitalized. This opens a possibility that Magnex treatment could cause the above reactions, including disseminated intravascular coagulation, and some male subjects may be more susceptible.

      Haemorrhage, Platelet Count Decreased
      A 70-year-old male patient (weight: NA) from INDIA with the following symptoms/conditions: pneumonia aspiration started Magnex treatment (dosage: NA) on NS. Soon after starting Magnex treatment, the subject experienced various side effects, including:
      • Haemorrhage
      • Platelet Count Decreased
      Concurrently used drugs:
      • Amikacin
      The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Magnex.

      1 of 2 



      Keep Track of Side Effects

      Note Your Observations

      It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

      Why Your Notes are Important

      Your notes could be helpful in several ways:

    • You can use them to remind you of details that may alert your health care professional(s) to a problem
    • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

    • Log Form

      You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

      Medicine Name and Dosage:
      Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
      Scale: 1 = very mild to 10 = very bad

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


      Discuss Magnex Side Effects

      Did You Have a Magnex Side Effect?

      Yes, Severe
      Yes, Moderate
      Yes, Minor
      No

      How Effective is Magnex for You?

      Exceeded Expectations
      Effective
      Somewhat Effective
      Not Effective

      Magnex Safety Alerts, Active Ingredients, Usage Information

      More About Magnex

      Side Effects reported to FDA: 49

      Magnex safety alerts: No

      Reported deaths: 14

      Reported hospitalizations: 7

      Latest Magnex clinical trials